Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Lineage Cell Therapeutics (BT3.STU) Q2 2026 Earnings
BT3.STU
12
May
Confirmed
Q1 2026
Next
-0.04
-0.02
-0.01
0
Details
Expected EPS
-0.016994000000000002
Actual EPS
N/A
Surprise EPS
0.02
Surprise Percent
+100%
Description
Lineage Cell Therapeutics (BT3.STU) will report earnings of for Q2 2026 on May 12, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist